Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clones

Tissue Antigens

Volumn 59, Issue 4, 2002, Pages 273-279

  Sensi, M ^a   Pellegatta, S ^a   Vegetti, C ^a   Nicolini, G ^a   Parmiani, G ^a   Anichini, A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

CTL; gp100 Pmel17; HLA A28; Melanoma; Tumor antigen

Indexed keywords

CD8 ANTIGEN; GLYCOPROTEIN GP 100; HLA A ANTIGEN; TUMOR NECROSIS FACTOR; EPITOPE; MELANOCYTE LINEAGE SPECIFIC ANTIGEN GP100; MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100; MEMBRANE PROTEIN; TUMOR ANTIGEN; TUMOR PROTEIN;

ALGORITHM; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; HLA SYSTEM; IMMUNOTHERAPY; LYMPHOCYTE CLONE; LYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MELANOMA; NONHUMAN; PEPTIDE ANALYSIS; PREDICTION; PRIORITY JOURNAL; TARGET CELL; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; CELL CLONE; CELL CULTURE; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; SKIN TUMOR; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CLONE CELLS; COS CELLS; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMAN; MELANOMA; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; ANIMALS; HUMANS;

ANIMALIA;

EID: 0036024178     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2002.590404.x     Document Type: Article

References (24)

1. Cancer tumor antigens
2. Peptide database of T-cell defined tumor antigens
3. A listing of human tumor antigens recognized by T cells
4. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating lymphocytes from 123 patients with melanoma
5. Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma
6. Molecular characterization of the melanocyte lineage-specific antigen gp100
7. Genomic organization and sequence of D12S53E (Pmel17), the human homologue of the mouse silver (si) locus
8. Immunologic and therapeutic evaluation of a synthetic tumor associated peptide vaccine for the treatment of patients with metastatic melanoma
9. + melanoma infiltrating lymphocytes (TIL): Implications for immunotherapy
10. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma
11. Conserved TCR usage by HLA-Cw*1601-restricted T cell clones recognizing melanoma antigens
12. Human melanocytes and melanomas express novel mRNA isoforms of the tyrosinase-related protein-2/DOPAchrome tautomerase gene: Molecular and functional characterization
13. Translation of a retained intron in tyrosinase-related protein-2 (TRP-2) mRNA generates a new cytotoxic T lymphocyte (CTL) defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage
14. IMGT/HLA database: A sequence database for the human major histocompatibility complex
15. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
16. Identification of five MAGE-A1 epitopes recognized by cytolitic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1
17. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis
18. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy
19. PAProC: A prediction algorithm for proteosomal cleavages available on the WWW
20. Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis
21. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells
22. Identification of helper T cell epitopes that encompass or lie proximal to cytotoxic T cell epitopes in the gp100 melanoma tumor antigen
23. + T-cell immunity in cancer patients
24. Phenotypic analysis of antigen-specific T lymphocytes